Inspire Medical Systems, Inc. to Report Third Quarter 2019 Financial Results on November 5, 2019

Download as PDF

MINNEAPOLIS – October 8, 2019 – Inspire Medical Systems, Inc. (NYSE: INSP)
(“Inspire”), a medical technology company focused on the development and
commercialization of innovative and minimally invasive solutions for patients with
obstructive sleep apnea, today announced that it will release financial results for the
third quarter 2019 after the close of trading on Tuesday, November 5. Inspire’s
management team will host a corresponding conference call beginning at 5:00 p.m.
Eastern Time to discuss the financial results and recent business developments.

Tuesday, November 5th @ 5:00 p.m. Eastern Time:
Domestic: 877-407-0792
International: 201-689-8263
Conference ID: 13695274
Webcast: http://public.viavid.com/index.php?id=136408

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and
commercialization of innovative and minimally invasive solutions for patients with
obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-
approved neurostimulation technology that provides a safe and effective treatment for
moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact:
Bob Yedid
LifeSci Advisors
inspire@lifesciadvisors.com
646-597-6989